back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-25 09:26 Tx date 2024-03-21 |
$VPH
VALEO PHARMA INC. |
Moghaddam, Ali Ghaderi
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-02-14 15:10 Tx date 2024-02-14 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
$2,271
+8,572 vol $0.265 each |
21,965 | |
| Filed 2024-02-14 15:08 Tx date 2024-02-14 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-3,549.145
-13,393 vol $0.265 each |
0 | |
| Filed 2024-02-13 17:20 Tx date 2024-02-12 |
$VPH
VALEO PHARMA INC. |
Bisaillon, Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-29 13:01 Tx date 2023-11-29 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
+13,393 vol |
13,393 | |
| Filed 2023-11-29 13:00 Tx date 2023-11-29 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
-13,393 vol |
13,393 | |
| Filed 2023-11-29 12:57 Tx date 2023-11-29 |
$VPH
VALEO PHARMA INC. |
Steiger, Kyle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
+19,394 vol |
19,394 | |
| Filed 2023-11-29 12:56 Tx date 2022-08-29 |
$VPH
VALEO PHARMA INC. |
Steiger, Kyle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-29 12:56 Tx date 2023-11-29 |
$VPH
VALEO PHARMA INC. |
Steiger, Kyle
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
-30,303 vol |
0 | |
| Filed 2023-11-22 09:50 Tx date 2023-11-20 |
$VPH
VALEO PHARMA INC. |
Tougas, Pascal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
300,000 | |
| Filed 2023-11-22 09:48 Tx date 2023-11-20 |
$VPH
VALEO PHARMA INC. |
Tougas, Pascal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-22 09:47 Tx date 2023-11-20 |
$VPH
VALEO PHARMA INC. |
Tougas, Pascal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-09 12:22 Tx date 2023-11-01 |
$VPH
VALEO PHARMA INC. |
Lajoie, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-28 17:53 Tx date 2023-09-25 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Common Shares Class A
38 - Redemption, retraction, cancellation, repurchase
|
+650,000 vol |
23,322,987 | |
| Filed 2023-09-28 10:40 Tx date 2023-09-25 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
38 - Redemption, retraction, cancellation, repurchase
|
+650,000 vol |
2,648,055 | |
| Filed 2023-09-26 13:50 Tx date 2023-09-25 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
38 - Redemption, retraction, cancellation, repurchase
|
+650,000 vol |
25,372,987 | |
| Filed 2023-09-25 13:24 Tx date 2023-09-20 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Simcor Canada Holdings Inc. (Control or Direction)
|
Common Shares Class A
11 - Acquisition or disposition carried out privately
|
$-130,000
-520,000 vol $0.25 each |
3,694,145 | |
| Filed 2023-09-25 13:12 Tx date 2023-09-20 |
$VPH
VALEO PHARMA INC. |
Simcor Canada Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
11 - Acquisition or disposition carried out privately
|
$-130,000
-520,000 vol $0.25 each |
1,694,145 | |
| Filed 2023-09-18 11:00 Tx date 2023-09-13 |
$VPH
VALEO PHARMA INC. |
Ecclestone, Pierre Leslie Conrad
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+180,000 vol |
180,000 | |
| Filed 2023-09-18 10:59 Tx date 2023-08-08 |
$VPH
VALEO PHARMA INC. |
Ecclestone, Pierre Leslie Conrad
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-14 17:57 Tx date 2023-09-13 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,750
+65,000 vol $0.35 each |
1,477,500 | |
| Filed 2023-09-11 16:28 Tx date 2023-08-31 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Warrants (31AUG2028, $0.35)
16 - Acquisition or disposition under a prospectus exemption
|
$156,249
+446,428 vol $0.35 each |
446,428 | |
| Filed 2023-09-11 16:27 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Warrants (31AUG2028, $0.35)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-11 16:25 Tx date 2023-08-31 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$249,999
+892,857 vol $0.28 each |
22,672,987 | |
| Filed 2023-09-06 13:59 Tx date 2022-07-25 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants VPH.WT (25JULY2022 Warrants)
55 - Expiration of warrants
|
-25,500 vol |
0 | |
| Filed 2023-09-01 12:55 Tx date 2023-08-31 |
$VPH
VALEO PHARMA INC. |
Investissement Québec
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024
00 - Opening Balance-Initial SEDI Report
|
$10,000,000 | ||
| Filed 2023-09-01 12:54 Tx date 2023-08-31 |
$VPH
VALEO PHARMA INC. |
Investissement Québec
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (31AUG2028, $0.35)
00 - Opening Balance-Initial SEDI Report
|
3,571,429 | ||
| Filed 2023-09-01 12:54 Tx date 2023-08-31 |
$VPH
VALEO PHARMA INC. |
Investissement Québec
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
7,142,857 | ||
| Filed 2023-09-01 12:31 Tx date 2023-08-31 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (31AUG2028, $0.35)
16 - Acquisition or disposition under a prospectus exemption
|
$156,249
+446,428 vol $0.35 each |
446,428 | |
| Filed 2023-09-01 12:28 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (31AUG2028, $0.35)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-01 12:27 Tx date 2023-08-31 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$232,142
+892,857 vol $0.26 each |
24,722,987 | |
| Filed 2023-09-01 11:54 Tx date 2023-08-31 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$1,169,999
+4,178,571 vol $0.28 each |
16,176,455 | |
| Filed 2023-09-01 11:54 Tx date 2023-08-31 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Warrants (31AUG2028, $0.35)
16 - Acquisition or disposition under a prospectus exemption
|
$731,249
+2,089,285 vol $0.35 each |
2,089,285 | |
| Filed 2023-09-01 11:53 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Warrants (31AUG2028, $0.35)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-01 11:52 Tx date 2023-08-31 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (31AUG2028, $0.35)
16 - Acquisition or disposition under a prospectus exemption
|
$731,249
+2,089,285 vol $0.35 each |
2,089,285 | |
| Filed 2023-09-01 11:51 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (31AUG2028, $0.35)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-01 11:51 Tx date 2023-08-31 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$1,169,999
+4,178,571 vol $0.28 each |
16,176,455 | |
| Filed 2023-09-01 11:48 Tx date 2023-08-31 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (31AUG2028, $0.35)
16 - Acquisition or disposition under a prospectus exemption
|
$624.75
+1,785 vol $0.35 each |
1,785 | |
| Filed 2023-09-01 11:47 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (31AUG2028, $0.35)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-01 11:41 Tx date 2023-08-31 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$999.88
+3,571 vol $0.28 each |
393,571 | |
| Filed 2023-08-30 13:46 Tx date 2022-12-21 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
$23,250
+50,000 vol $0.465 each |
1,358,369 | |
| Filed 2022-12-21 13:53 Tx date 2022-12-21 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
$2,500,000,000
+50,000 vol $50,000 each |
||
| Filed 2023-08-28 14:08 Tx date 2022-07-25 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Warrants VPH.WT (25JULY2022 Warrants)
55 - Expiration of warrants
|
-200,000 vol |
0 | |
| Filed 2023-08-28 13:44 Tx date 2023-04-26 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Warrants (26APRIL2023, $1.60)
55 - Expiration of warrants
|
-40,000 vol |
0 | |
| Filed 2023-08-28 13:42 Tx date 2023-04-26 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (26APRIL2023, $1.60)
55 - Expiration of warrants
|
-400,000 vol |
0 | |
| Filed 2023-08-18 15:45 Tx date 2023-08-18 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$32,000
+100,000 vol $0.32 each |
1,998,055 | |
| Filed 2023-07-26 15:35 Tx date 2021-06-29 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$100,000
+100,000 vol $1.00 each |
8,254,965 | |
| Filed 2023-07-26 15:34 Tx date 2022-03-04 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
36 - Conversion or exchange
|
$1,367
+3,419 vol $0.40 each |
11,367,384 | |
| Filed 2023-07-26 15:33 Tx date 2022-03-04 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
36 - Conversion or exchange
|
$1,040,000
+2,600,000 vol $0.40 each |
11,363,965 | |
| Filed 2023-05-01 13:27 Tx date 2023-04-27 |
$VPH
VALEO PHARMA INC. |
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-01 11:10 Tx date 2023-04-27 |
$VPH
VALEO PHARMA INC. |
Brennan, Maureen
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
-27,778 vol |
0 | |
| Filed 2023-05-01 10:40 Tx date 2023-04-27 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
+37,037 vol |
641,972 | |
| Filed 2023-05-01 10:40 Tx date 2023-04-27 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
-37,037 vol |
0 | |
| Filed 2023-05-01 10:37 Tx date 2023-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
+27,778 vol |
2,331,414 | |
| Filed 2023-05-01 10:36 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
2,303,636 | ||
| Filed 2023-05-01 10:34 Tx date 2023-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
-27,778 vol |
0 | |
| Filed 2023-05-01 10:32 Tx date 2023-04-27 |
$VPH
VALEO PHARMA INC. |
Brennan, Maureen
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
+27,778 vol |
27,778 | |
| Filed 2023-05-01 10:31 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Brennan, Maureen
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-01 10:31 Tx date 2023-03-27 |
$VPH
VALEO PHARMA INC. |
Brennan, Maureen
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
-27,778 vol |
||
| Filed 2023-05-01 10:31 Tx date 2023-03-27 |
$VPH
VALEO PHARMA INC. |
Brennan, Maureen
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
-27,778 vol |
0 | |
| Filed 2023-05-01 10:28 Tx date 2023-04-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
+46,296 vol |
46,296 | |
| Filed 2023-05-01 10:27 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-01 10:27 Tx date 2023-04-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
-46,296 vol |
0 | |
| Filed 2023-03-22 18:40 Tx date 2023-03-15 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$264,000
+400,000 vol $0.66 each |
550,000 | |
| Filed 2023-03-17 12:05 Tx date 2023-03-15 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$198,000
+300,000 vol $0.66 each |
1,412,500 | |
| Filed 2023-03-17 10:16 Tx date 2023-03-15 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$66,000
+100,000 vol $0.66 each |
275,000 | |
| Filed 2023-03-17 10:14 Tx date 2023-03-15 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$66,000
+100,000 vol $0.66 each |
447,222 | |
| Filed 2023-03-17 10:12 Tx date 2023-03-15 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$66,000
+100,000 vol $0.66 each |
225,000 | |
| Filed 2023-03-17 10:10 Tx date 2023-03-15 |
$VPH
VALEO PHARMA INC. |
Steiger, Kyle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$99,000
+150,000 vol $0.66 each |
650,000 | |
| Filed 2023-03-17 10:07 Tx date 2023-03-15 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$66,000
+100,000 vol $0.66 each |
300,000 | |
| Filed 2023-03-17 10:04 Tx date 2023-03-15 |
$VPH
VALEO PHARMA INC. |
Steiger, Kyle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$99,000
+150,000 vol $0.66 each |
||
| Filed 2023-02-27 14:28 Tx date 2023-02-27 |
$VPH
VALEO PHARMA INC. |
Hogue, Vincent
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
36 - Conversion or exchange
|
$105,966
+264,917 vol $0.40 each |
517,323 | |
| Filed 2023-02-27 14:26 Tx date 2023-02-27 |
$VPH
VALEO PHARMA INC. |
Hogue, Vincent
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price)
36 - Conversion or exchange
|
$
-$100,000 vol $0.40 each |
$0 | |
| Filed 2023-02-07 15:34 Tx date 2023-02-02 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
36 - Conversion or exchange
|
+404,935 vol |
604,935 | |
| Filed 2023-02-07 15:32 Tx date 2023-02-07 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price)
36 - Conversion or exchange
|
$
-$154,000 vol $0.40 each |
$0 | |
| Filed 2023-01-31 15:02 Tx date 2023-01-27 |
$VPH
VALEO PHARMA INC. |
Saviuk, Helen
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
56 - Grant of rights
|
$16,800
+30,000 vol $0.56 each |
30,000 | |
| Filed 2023-01-31 15:01 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Saviuk, Helen
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-31 13:27 Tx date 2023-01-27 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
56 - Grant of rights
|
$54,000
+96,429 vol $0.56 each |
96,429 | |
| Filed 2023-01-31 13:25 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-31 07:22 Tx date 2023-01-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
56 - Grant of rights
|
$100,000
+178,572 vol $0.56 each |
178,572 | |
| Filed 2023-01-31 07:19 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-29 10:51 Tx date 2023-01-27 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$15,000
+26,786 vol $0.56 each |
26,786 | |
| Filed 2023-01-29 10:49 Tx date 2021-06-15 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-29 10:46 Tx date 2023-01-27 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
56 - Grant of rights
|
$17,500
+31,250 vol $0.56 each |
31,250 | |
| Filed 2023-01-29 10:44 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-29 10:41 Tx date 2023-01-27 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
56 - Grant of rights
|
$12,375
+22,099 vol $0.56 each |
22,099 | |
| Filed 2023-01-29 10:41 Tx date 2023-01-27 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
56 - Grant of rights
|
$21,000
+37,500 vol $0.56 each |
37,500 | |
| Filed 2023-01-29 10:39 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-29 10:39 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-21 13:53 Tx date 2022-12-21 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
$2,500,000,000
+50,000 vol $50,000 each |
1,358,369 | |
| Filed 2022-12-21 13:52 Tx date 2022-12-21 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
-50,000 vol |
0 | |
| Filed 2022-11-25 10:47 Tx date 2022-11-25 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
$13,250
+25,000 vol $0.53 each |
1,402,150 | |
| Filed 2022-11-25 10:45 Tx date 2022-11-25 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-13,250
-25,000 vol $0.53 each |
0 | |
| Filed 2022-11-23 15:51 Tx date 2022-11-21 |
$VPH
VALEO PHARMA INC. |
Fasano, Frederic
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-2,050,000 vol |
0 | |
| Filed 2022-10-07 16:55 Tx date 2022-10-05 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$5,200
+10,000 vol $0.52 each |
180,745 | |
| Filed 2022-09-29 14:51 Tx date 2022-09-22 |
$VPH
VALEO PHARMA INC. |
Simcor Canada Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
11 - Acquisition or disposition carried out privately
|
$-1,160,000
-2,000,000 vol $0.58 each |
2,214,145 | |
| Filed 2022-09-29 12:59 Tx date 2022-07-25 |
$VPH
VALEO PHARMA INC. |
Saviuk, Helen
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Klug Investments Inc (Indirect Ownership)
|
Warrants VPH.WT (25JULY2022 Warrants)
55 - Expiration of warrants
|
-32,909 vol |
0 | |
| Filed 2022-09-29 12:52 Tx date 2022-07-25 |
$VPH
VALEO PHARMA INC. |
Saviuk, Helen
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants VPH.WT (25JULY2022 Warrants)
55 - Expiration of warrants
|
-58,428 vol |
0 | |
| Filed 2022-09-29 12:25 Tx date 2022-07-25 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants VPH.WT (25JULY2022 Warrants)
55 - Expiration of warrants
|
-360,515 vol |
25,500 | |
| Filed 2022-09-29 12:06 Tx date 2022-09-22 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
11 - Acquisition or disposition carried out privately
|
$1,160,000
+2,000,000 vol $0.58 each |
23,830,130 | |
| Filed 2022-09-26 11:21 Tx date 2022-07-10 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Warrants VPH.WT (25JULY2022 Warrants)
55 - Expiration of warrants
|
-75,000 vol |
200,000 | |
| Filed 2022-09-26 10:31 Tx date 2022-09-10 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Warrants VPH.WT. A.(10SEP2022 Warrants)
55 - Expiration of warrants
|
-42,000 vol |
0 | |
| Filed 2022-09-26 10:30 Tx date 2022-07-10 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Warrants VPH.WT (25JULY2022 Warrants)
55 - Expiration of warrants
|
-225,000 vol |
502,204 | |
| Filed 2022-09-26 10:29 Tx date 2022-07-25 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Warrants VPH.WT (25JULY2022 Warrants)
55 - Expiration of warrants
|
-502,204 vol |
0 | |
| Filed 2022-09-26 10:25 Tx date 2022-07-10 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Warrants VPH.WT (25JULY2022 Warrants)
55 - Expiration of warrants
|
-22,500 vol |
0 | |
| Filed 2022-09-26 10:24 Tx date 2022-07-25 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants VPH.WT (25JULY2022 Warrants)
55 - Expiration of warrants
|
-100 vol |
0 | |
| Filed 2022-09-26 10:05 Tx date 2022-07-10 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants VPH.WT (25JULY2022 Warrants)
55 - Expiration of warrants
|
-225,000 vol |
502,204 | |
| Filed 2022-09-26 10:00 Tx date 2022-09-10 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants VPH.WT. A.(10SEP2022 Warrants)
55 - Expiration of warrants
|
-42,000 vol |
0 | |
| Filed 2022-09-26 09:58 Tx date 2022-07-25 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants VPH.WT (25JULY2022 Warrants)
55 - Expiration of warrants
|
-502,204 vol |
225,000 | |
| Filed 2022-09-13 13:50 Tx date 2022-09-13 |
$VPH
VALEO PHARMA INC. |
Steiger, Kyle
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$19,999
+30,303 vol $0.66 each |
30,303 | |
| Filed 2022-09-13 13:43 Tx date 2022-08-29 |
$VPH
VALEO PHARMA INC. |
Steiger, Kyle
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-09-13 13:41 Tx date 2022-09-13 |
$VPH
VALEO PHARMA INC. |
Steiger, Kyle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
| Filed 2022-09-13 13:39 Tx date 2022-08-29 |
$VPH
VALEO PHARMA INC. |
Steiger, Kyle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-27 16:25 Tx date 2022-06-23 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$9,600
+16,000 vol $0.60 each |
170,745 | |
| Filed 2022-06-22 09:25 Tx date 2022-06-15 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$7,750
+15,500 vol $0.50 each |
8,679,465 | |
| Filed 2022-06-22 09:19 Tx date 2022-06-20 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$29,071
+49,500 vol $0.59 each |
11,797,884 | |
| Filed 2022-06-22 09:18 Tx date 2022-06-20 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$28,999
+50,000 vol $0.58 each |
11,748,384 | |
| Filed 2022-06-22 09:16 Tx date 2022-06-20 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$29,071
+49,500 vol $0.59 each |
9,094,465 | |
| Filed 2022-06-22 09:15 Tx date 2022-06-20 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$28,999
+50,000 vol $0.58 each |
9,044,965 | |
| Filed 2022-06-22 08:47 Tx date 2022-06-21 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$30,950
+50,000 vol $0.62 each |
9,194,465 | |
| Filed 2022-06-22 08:47 Tx date 2022-06-21 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$30,900
+50,000 vol $0.62 each |
9,144,465 | |
| Filed 2022-06-22 08:46 Tx date 2022-06-21 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$30,900
+50,000 vol $0.62 each |
9,094,465 | |
| Filed 2022-06-22 08:46 Tx date 2022-06-21 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$30,500
+50,000 vol $0.61 each |
9,044,465 | |
| Filed 2022-06-22 08:45 Tx date 2022-06-21 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$30,950
+50,000 vol $0.62 each |
11,898,384 | |
| Filed 2022-06-22 08:44 Tx date 2022-06-21 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$30,900
+50,000 vol $0.62 each |
11,848,384 | |
| Filed 2022-06-22 08:44 Tx date 2022-06-21 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$30,900
+50,000 vol $0.62 each |
11,798,384 | |
| Filed 2022-06-22 08:44 Tx date 2022-06-21 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$30,500
+50,000 vol $0.61 each |
11,748,384 | |
| Filed 2022-06-17 12:45 Tx date 2022-06-15 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$7,500
+15,000 vol $0.50 each |
||
| Filed 2022-06-20 17:29 Tx date 2022-06-17 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$28,000
+50,000 vol $0.56 each |
8,994,465 | |
| Filed 2022-06-20 17:28 Tx date 2022-06-17 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$21,450
+39,000 vol $0.55 each |
8,944,465 | |
| Filed 2022-06-20 17:28 Tx date 2022-06-17 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$13,750
+25,000 vol $0.55 each |
8,905,465 | |
| Filed 2022-06-20 17:26 Tx date 2022-06-17 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$28,000
+50,000 vol $0.56 each |
11,698,384 | |
| Filed 2022-06-20 17:25 Tx date 2022-06-17 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$21,450
+39,000 vol $0.55 each |
11,648,384 | |
| Filed 2022-06-20 17:25 Tx date 2022-06-17 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$14,000
+25,000 vol $0.56 each |
11,609,384 | |
| Filed 2022-06-17 12:50 Tx date 2022-06-16 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$26,465
+50,000 vol $0.53 each |
8,853,965 | |
| Filed 2022-06-17 12:48 Tx date 2022-06-16 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$14,378
+26,500 vol $0.54 each |
8,880,465 | |
| Filed 2022-06-17 12:48 Tx date 2022-06-16 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$27,130
+50,000 vol $0.54 each |
||
| Filed 2022-06-17 12:47 Tx date 2022-06-15 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$13,500
+25,000 vol $0.54 each |
8,803,965 | |
| Filed 2022-06-17 12:46 Tx date 2022-06-15 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$26,395
+50,000 vol $0.53 each |
8,778,965 | |
| Filed 2022-06-17 12:45 Tx date 2022-06-15 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$24,790
+50,000 vol $0.4958 each |
8,728,965 | |
| Filed 2022-06-17 12:45 Tx date 2022-06-15 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$7,500
+15,000 vol $0.50 each |
8,678,965 | |
| Filed 2022-06-17 12:41 Tx date 2022-06-16 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$14,378
+26,500 vol $0.54 each |
11,584,384 | |
| Filed 2022-06-17 12:40 Tx date 2022-06-16 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$26,465
+50,000 vol $0.53 each |
11,557,884 | |
| Filed 2022-06-17 12:39 Tx date 2022-06-15 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$13,500
+25,000 vol $0.54 each |
11,507,884 | |
| Filed 2022-06-17 12:39 Tx date 2022-06-15 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$26,395
+50,000 vol $0.53 each |
11,482,884 | |
| Filed 2022-06-17 12:38 Tx date 2022-06-15 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$24,790
+50,000 vol $0.4958 each |
11,432,884 | |
| Filed 2022-06-17 12:37 Tx date 2022-06-15 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$7,750
+15,500 vol $0.50 each |
11,382,884 | |
| Filed 2022-05-02 14:02 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Hogue, Vincent
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$19,999
+37,037 vol $0.54 each |
37,037 | |
| Filed 2022-05-02 14:01 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$19,999
+37,037 vol $0.54 each |
37,037 | |
| Filed 2022-05-02 14:00 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$15,000
+27,778 vol $0.54 each |
27,778 | |
| Filed 2022-05-02 13:59 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Brennan, Maureen
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$15,000
+27,778 vol $0.54 each |
27,778 | |
| Filed 2022-05-02 13:57 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$24,999
+46,296 vol $0.54 each |
46,296 | |
| Filed 2022-05-02 13:27 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Saviuk, Helen
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,500
+25,000 vol $0.66 each |
125,000 | |
| Filed 2022-05-02 13:02 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2022-05-02 13:01 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$8,100
+15,000 vol $0.54 each |
||
| Filed 2022-05-02 13:01 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$8,100
+15,000 vol $0.54 each |
15,000 | |
| Filed 2022-05-02 13:01 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-02 13:00 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
150,000 | |
| Filed 2022-05-02 13:00 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-02 12:17 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
200,000 | |
| Filed 2022-05-02 12:16 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Brien, Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
165,000 | |
| Filed 2022-05-02 12:15 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
125,000 | |
| Filed 2022-05-02 12:13 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
347,222 | |
| Filed 2022-05-02 12:12 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
175,000 | |
| Filed 2022-05-02 12:11 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Fasano, Frederic
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
2,050,000 | |
| Filed 2022-05-02 11:55 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Hogue, Vincent
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$10,800
+20,000 vol $0.54 each |
||
| Filed 2022-05-02 11:55 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Hogue, Vincent
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$10,800
+20,000 vol $0.54 each |
20,000 | |
| Filed 2022-05-02 11:55 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Hogue, Vincent
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-02 11:55 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Hogue, Vincent
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
215,000 | |
| Filed 2022-05-02 11:53 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$10,800
+20,000 vol $0.54 each |
20,000 | |
| Filed 2022-05-02 11:53 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$10,800
+20,000 vol $0.54 each |
||
| Filed 2022-05-02 11:53 Tx date 2019-09-24 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-02 11:53 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
215,000 | |
| Filed 2022-05-02 11:51 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Brennan, Maureen
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$8,100
+15,000 vol $0.54 each |
||
| Filed 2022-05-02 11:51 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Brennan, Maureen
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$8,100
+15,000 vol $0.54 each |
15,000 | |
| Filed 2022-05-02 11:51 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Brennan, Maureen
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-02 11:50 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Brennan, Maureen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
215,000 | |
| Filed 2022-05-02 11:49 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$13,500
+25,000 vol $0.54 each |
25,000 | |
| Filed 2022-05-02 11:49 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$13,500
+25,000 vol $0.54 each |
||
| Filed 2022-05-02 11:45 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-02 11:43 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
15,000 | |
| Filed 2022-05-02 11:42 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-30 09:40 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,750
+37,500 vol $0.66 each |
1,112,500 | |
| Filed 2022-03-09 12:42 Tx date 2022-03-04 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
36 - Conversion or exchange
|
$1,367
+3,419 vol $0.40 each |
11,367,384 | |
| Filed 2022-03-09 12:40 Tx date 2022-03-04 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
36 - Conversion or exchange
|
$1,040,000
+2,600,000 vol $0.40 each |
11,363,965 | |
| Filed 2022-03-09 12:38 Tx date 2022-03-04 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price)
36 - Conversion or exchange
|
$
-$1,040,000 vol $0.40 each |
$0 | |
| Filed 2021-12-10 13:09 Tx date 2021-12-09 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
36 - Conversion or exchange
|
-$50,000 vol |
$0 | |
| Filed 2021-12-10 13:08 Tx date 2021-12-09 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Debentures Non-Convertible, Unsecured, 8%, 9 months
36 - Conversion or exchange
|
-$200,000 vol |
$0 | |
| Filed 2021-12-10 12:59 Tx date 2021-12-09 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024
16 - Acquisition or disposition under a prospectus exemption
|
+$250,000 vol |
$250,000 | |
| Filed 2021-12-10 12:58 Tx date 2019-09-24 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-10 12:54 Tx date 2021-12-09 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024
16 - Acquisition or disposition under a prospectus exemption
|
+$20,000 vol |
$20,000 | |
| Filed 2021-12-10 12:53 Tx date 2021-06-15 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-10 12:51 Tx date 2021-12-09 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024
16 - Acquisition or disposition under a prospectus exemption
|
+$1,540,000 vol |
$1,540,000 | |
| Filed 2021-12-10 12:50 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-10 12:35 Tx date 2021-12-09 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Debentures Non-Convertible, Unsecured, 8%, 9 months
36 - Conversion or exchange
|
-$1,540,000 vol |
$460,000 | |
| Filed 2021-12-10 12:34 Tx date 2021-12-09 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024
16 - Acquisition or disposition under a prospectus exemption
|
+$1,540,000 vol |
$1,540,000 | |
| Filed 2021-12-10 12:27 Tx date 2021-12-09 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Debentures (Non-Convertible) July 2020
36 - Conversion or exchange
|
-$15,000 vol |
$0 | |
| Filed 2021-12-10 12:25 Tx date 2021-12-09 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024
16 - Acquisition or disposition under a prospectus exemption
|
+$25,000 vol |
$25,000 | |
| Filed 2021-12-10 12:24 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-10 12:02 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-10-20 15:02 Tx date 2021-10-20 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$45,000
+50,000 vol $0.90 each |
8,663,965 | |
| Filed 2021-10-20 15:02 Tx date 2021-10-20 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$45,000
+50,000 vol $0.90 each |
8,613,965 | |
| Filed 2021-10-20 14:57 Tx date 2021-10-20 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$45,000
+50,000 vol $0.90 each |
8,763,965 | |
| Filed 2021-10-20 14:56 Tx date 2021-10-20 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$45,000
+50,000 vol $0.90 each |
8,713,965 | |
| Filed 2021-10-07 13:38 Tx date 2021-10-07 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$45,000
+50,000 vol $0.90 each |
8,563,965 | |
| Filed 2021-10-07 13:37 Tx date 2021-10-07 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$45,000
+50,000 vol $0.90 each |
8,513,965 | |
| Filed 2021-10-07 13:37 Tx date 2021-10-07 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$45,000
+50,000 vol $0.90 each |
8,463,965 | |
| Filed 2021-10-07 13:36 Tx date 2021-10-07 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$45,000
+50,000 vol $0.90 each |
8,413,965 | |
| Filed 2021-10-07 13:25 Tx date 2021-10-07 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$45,000
+50,000 vol $0.90 each |
8,663,965 | |
| Filed 2021-10-07 13:24 Tx date 2021-10-07 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$45,000
+50,000 vol $0.90 each |
8,613,965 | |
| Filed 2021-10-07 13:24 Tx date 2021-10-07 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$45,000
+50,000 vol $0.90 each |
8,563,965 | |
| Filed 2021-10-07 13:23 Tx date 2021-10-07 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$45,000
+50,000 vol $0.90 each |
8,513,965 | |
| Filed 2021-10-05 14:08 Tx date 2021-10-05 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$44,000
+50,000 vol $0.88 each |
393,000 | |
| Filed 2021-10-05 07:51 Tx date 2021-10-01 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$37,500
+50,000 vol $0.75 each |
8,363,965 | |
| Filed 2021-10-05 07:50 Tx date 2021-10-01 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$37,500
+50,000 vol $0.75 each |
8,313,965 | |
| Filed 2021-10-05 07:22 Tx date 2021-10-01 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$37,500
+50,000 vol $0.75 each |
8,463,965 | |
| Filed 2021-10-05 07:22 Tx date 2021-10-01 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$37,500
+50,000 vol $0.75 each |
8,413,965 | |
| Filed 2021-10-01 11:24 Tx date 2021-10-01 |
$VPH
VALEO PHARMA INC. |
Brien, Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
| Filed 2021-10-01 11:23 Tx date 2021-10-01 |
$VPH
VALEO PHARMA INC. |
Brien, Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-10-01 09:29 Tx date 2021-09-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$78,174
+109,000 vol $0.72 each |
8,263,965 | |
| Filed 2021-09-30 15:29 Tx date 2021-09-27 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$78,174
+109,000 vol $0.72 each |
8,363,965 | |
| Filed 2021-09-29 17:25 Tx date 2021-09-28 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$14,820
+19,000 vol $0.78 each |
154,745 | |
| Filed 2021-09-27 13:24 Tx date 2021-09-27 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$32,908
+43,300 vol $0.76 each |
1,377,150 | |
| Filed 2021-07-23 07:38 Tx date 2021-07-22 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$40,500
+67,500 vol $0.60 each |
1,898,055 | |
| Filed 2021-07-16 07:45 Tx date 2021-07-15 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$100,005
+150,000 vol $0.67 each |
1,830,555 | |
| Filed 2021-06-29 17:25 Tx date 2021-06-29 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants (29JUNE2024, $1.25)
15 - Acquisition or disposition under a prospectus
|
+200,000 vol |
200,000 | |
| Filed 2021-06-29 17:23 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants (29JUNE2024, $1.25)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-29 17:22 Tx date 2021-06-29 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$200,000
+200,000 vol $1.00 each |
343,000 | |
| Filed 2021-06-29 15:07 Tx date 2021-06-29 |
$VPH
VALEO PHARMA INC. |
Fasano, Frederic
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (29JUNE2024, $1.25)
15 - Acquisition or disposition under a prospectus
|
+25,000 vol |
25,000 | |
| Filed 2021-06-29 15:06 Tx date 2021-01-18 |
$VPH
VALEO PHARMA INC. |
Fasano, Frederic
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (29JUNE2024, $1.25)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-29 15:06 Tx date 2021-06-29 |
$VPH
VALEO PHARMA INC. |
Fasano, Frederic
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$25,000
+25,000 vol $1.00 each |
199,300 | |
| Filed 2021-06-29 15:02 Tx date 2021-06-29 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (29JUNE2024, $1.25)
15 - Acquisition or disposition under a prospectus
|
+100,000 vol |
100,000 | |
| Filed 2021-06-29 15:01 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (29JUNE2024, $1.25)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-29 15:00 Tx date 2021-06-29 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$100,000
+100,000 vol $1.00 each |
8,254,965 | |
| Filed 2021-06-17 09:59 Tx date 2021-06-15 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
| Filed 2021-06-17 09:58 Tx date 2021-06-15 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-17 09:57 Tx date 2021-06-15 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-26 08:46 Tx date 2021-05-25 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$28,000
+25,000 vol $1.12 each |
25,000 | |
| Filed 2021-05-26 08:45 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-26 08:43 Tx date 2021-05-25 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$56,000
+50,000 vol $1.12 each |
50,000 | |
| Filed 2021-05-26 08:41 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-26 08:39 Tx date 2021-05-25 |
$VPH
VALEO PHARMA INC. |
Fasano, Frederic
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$448,000
+400,000 vol $1.12 each |
400,000 | |
| Filed 2021-05-26 08:38 Tx date 2021-01-18 |
$VPH
VALEO PHARMA INC. |
Fasano, Frederic
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-26 08:38 Tx date 2021-05-25 |
$VPH
VALEO PHARMA INC. |
Fasano, Frederic
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
2,000,000 | |
| Filed 2021-05-07 09:35 Tx date 2021-05-07 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$626.58
+531 vol $1.18 each |
390,000 | |
| Filed 2021-05-07 09:19 Tx date 2021-05-04 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$1,180
+1,000 vol $1.18 each |
389,469 | |
| Filed 2021-05-07 09:18 Tx date 2021-05-04 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$1,770
+1,500 vol $1.18 each |
6,500 | |
| Filed 2021-05-07 09:17 Tx date 2021-05-04 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$1,770
+1,500 vol $1.18 each |
||
| Filed 2021-05-07 09:16 Tx date 2021-05-03 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$2,925
+2,500 vol $1.17 each |
388,469 | |
| Filed 2021-04-27 16:31 Tx date 2021-04-26 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Warrants (26APRIL2023, $1.60)
16 - Acquisition or disposition under a prospectus exemption
|
$64,000
+40,000 vol $1.60 each |
40,000 | |
| Filed 2021-04-27 16:30 Tx date 2019-09-24 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Warrants (26APRIL2023, $1.60)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-27 16:29 Tx date 2021-04-26 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Debentures Non-Convertible, Unsecured, 8%, 9 months
16 - Acquisition or disposition under a prospectus exemption
|
+$200,000 vol |
$200,000 | |
| Filed 2021-04-27 16:27 Tx date 2019-09-24 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Debentures Non-Convertible, Unsecured, 8%, 9 months
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-27 16:02 Tx date 2021-04-27 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
51 - Exercise of options
|
$3,537
+22,110 vol $0.16 each |
1,333,850 | |
| Filed 2021-04-27 16:01 Tx date 2021-04-27 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-22,110 vol |
100,000 | |
| Filed 2021-04-27 16:00 Tx date 2021-04-23 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
51 - Exercise of options
|
$38,992
+243,700 vol $0.16 each |
1,311,740 | |
| Filed 2021-04-27 15:59 Tx date 2021-04-23 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-243,700 vol |
122,110 | |
| Filed 2021-04-27 15:57 Tx date 2021-04-20 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
40 - Short sale
|
$-18,279.90
-17,100 vol $1.07 each |
1,068,040 | |
| Filed 2021-04-27 15:56 Tx date 2021-04-19 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
40 - Short sale
|
$-5,450
-5,000 vol $1.09 each |
1,085,140 | |
| Filed 2021-04-27 15:55 Tx date 2021-04-16 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
40 - Short sale
|
$-11.50
-10 vol $1.15 each |
990,140 | |
| Filed 2021-04-27 15:02 Tx date 2021-04-26 |
$VPH
VALEO PHARMA INC. |
Hogue, Vincent
4 - Director of Issuer
Direct Ownership
|
Warrants (26APRIL2023, $1.60)
16 - Acquisition or disposition under a prospectus exemption
|
$32,000
+20,000 vol $1.60 each |
20,000 | |
| Filed 2021-04-27 15:01 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Hogue, Vincent
4 - Director of Issuer
Direct Ownership
|
Warrants (26APRIL2023, $1.60)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-27 15:01 Tx date 2021-04-26 |
$VPH
VALEO PHARMA INC. |
Hogue, Vincent
4 - Director of Issuer
Direct Ownership
|
Debentures Non-Convertible, Unsecured, 8%, 9 months
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100,000 vol $100,000 each |
$100,000 | |
| Filed 2021-04-27 15:00 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Hogue, Vincent
4 - Director of Issuer
Direct Ownership
|
Debentures Non-Convertible, Unsecured, 8%, 9 months
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-27 14:54 Tx date 2021-04-26 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (26APRIL2023, $1.60)
16 - Acquisition or disposition under a prospectus exemption
|
$640,000
+400,000 vol $1.60 each |
400,000 | |
| Filed 2021-04-27 14:46 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (26APRIL2023, $1.60)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-27 12:11 Tx date 2021-04-26 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Debentures Non-Convertible, Unsecured, 8%, 9 months
16 - Acquisition or disposition under a prospectus exemption
|
+$2,000,000 vol |
$2,000,000 | |
| Filed 2021-04-27 12:05 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Debentures Non-Convertible, Unsecured, 8%, 9 months
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-23 13:14 Tx date 2021-04-23 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$5,471
+4,800 vol $1.14 each |
143,000 | |
| Filed 2021-04-22 06:24 Tx date 2021-04-21 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$10,710
+10,200 vol $1.05 each |
138,200 | |
| Filed 2021-04-20 10:56 Tx date 2021-04-19 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
51 - Exercise of options
|
$16,000
+100,000 vol $0.16 each |
1,090,150 | |
| Filed 2021-04-20 10:55 Tx date 2021-04-19 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-100,000 vol |
365,810 | |
| Filed 2021-04-20 10:54 Tx date 2021-04-15 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
40 - Short sale
|
$-113,250
-100,000 vol $1.13 each |
990,150 | |
| Filed 2021-04-19 07:05 Tx date 2021-04-15 |
$VPH
VALEO PHARMA INC. |
Fasano, Frederic
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$175,901
+154,300 vol $1.14 each |
174,300 | |
| Filed 2021-04-17 11:05 Tx date 2021-04-14 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$5,500
+5,000 vol $1.10 each |
385,969 | |
| Filed 2021-04-09 10:11 Tx date 2021-04-07 |
$VPH
VALEO PHARMA INC. |
Fasano, Frederic
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$23,000
+20,000 vol $1.15 each |
20,000 | |
| Filed 2021-01-18 15:36 Tx date 2021-01-18 |
$VPH
VALEO PHARMA INC. |
Fasano, Frederic
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,950,000 vol |
1,950,000 | |
| Filed 2021-01-18 15:35 Tx date 2021-01-18 |
$VPH
VALEO PHARMA INC. |
Fasano, Frederic
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-18 15:34 Tx date 2021-01-18 |
$VPH
VALEO PHARMA INC. |
Fasano, Frederic
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-16 12:42 Tx date 2020-09-10 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$100,800
+84,000 vol $1.20 each |
8,154,965 | |
| Filed 2020-09-16 12:35 Tx date 2020-09-10 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Warrants VPH.WT. A.(10SEP2022 Warrants)
15 - Acquisition or disposition under a prospectus
|
+42,000 vol |
42,000 | |
| Filed 2020-09-16 12:35 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Warrants VPH.WT. A.(10SEP2022 Warrants)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-16 12:34 Tx date 2020-09-10 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$100,800
+84,000 vol $1.20 each |
8,154,965 | |
| Filed 2020-09-16 12:27 Tx date 2020-09-10 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants VPH.WT. A.(10SEP2022 Warrants)
15 - Acquisition or disposition under a prospectus
|
+42,000 vol |
42,000 | |
| Filed 2020-09-16 12:25 Tx date 2020-09-10 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants VPH.WT. A.(10SEP2022 Warrants)
15 - Acquisition or disposition under a prospectus
|
+42,000 vol |
||
| Filed 2020-09-16 12:23 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants VPH.WT. A.(10SEP2022 Warrants)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-16 12:22 Tx date 2020-09-10 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$8,467,200,000
+84,000 vol $100,800 each |
||
| Filed 2020-09-14 11:19 Tx date 2020-09-10 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants VPH.WT. A.(10SEP2022 Warrants)
15 - Acquisition or disposition under a prospectus
|
+12,500 vol |
12,500 | |
| Filed 2020-09-14 11:12 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants VPH.WT. A.(10SEP2022 Warrants)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-14 11:12 Tx date 2020-09-10 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$30,000
+25,000 vol $1.20 each |
1,680,555 | |
| Filed 2020-08-05 10:05 Tx date 2020-08-05 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$28,400
+20,000 vol $1.42 each |
135,745 | |
| Filed 2020-07-15 10:46 Tx date 2020-07-15 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$12,456
+8,650 vol $1.44 each |
1,090,150 | |
| Filed 2020-07-14 08:10 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+75,000 vol |
275,000 | |
| Filed 2020-07-14 08:09 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
16 - Acquisition or disposition under a prospectus exemption
|
+$50,000 vol |
$50,000 | |
| Filed 2020-07-14 08:09 Tx date 2019-09-24 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-14 08:05 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Wells, Michael G.
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+102,000 vol |
102,000 | |
| Filed 2020-07-14 08:04 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Wells, Michael G.
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-14 08:03 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Wells, Michael G.
4 - Director of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
16 - Acquisition or disposition under a prospectus exemption
|
+$68,000 vol |
$68,000 | |
| Filed 2020-07-14 08:02 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Wells, Michael G.
4 - Director of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-14 08:01 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+22,500 vol |
22,500 | |
| Filed 2020-07-14 08:00 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-14 07:59 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
16 - Acquisition or disposition under a prospectus exemption
|
+$15,000 vol |
$15,000 | |
| Filed 2020-07-14 07:59 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-14 07:43 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+225,000 vol |
727,204 | |
| Filed 2020-07-14 07:42 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Debentures (Non-Convertible) July 2020
16 - Acquisition or disposition under a prospectus exemption
|
+$150,000 vol |
$150,000 | |
| Filed 2020-07-14 07:41 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Debentures (Non-Convertible) July 2020
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-14 07:39 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+225,000 vol |
727,204 | |
| Filed 2020-07-14 07:37 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
16 - Acquisition or disposition under a prospectus exemption
|
+$150,000 vol |
$150,000 | |
| Filed 2020-07-14 07:36 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-13 15:51 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+82,500 vol |
701,000 | |
| Filed 2020-07-13 15:49 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
16 - Acquisition or disposition under a prospectus exemption
|
+$55,000 vol |
$55,000 | |
| Filed 2020-07-13 15:43 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-13 12:01 Tx date 2020-07-13 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$19,440
+13,500 vol $1.44 each |
1,081,500 | |
| Filed 2020-07-13 11:55 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
11 - Acquisition or disposition carried out privately
|
+$17,000 vol |
$17,000 | |
| Filed 2020-07-13 11:54 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-13 11:49 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$15,000 vol |
||
| Filed 2020-07-13 11:48 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Debentures (Non-Convertible) July 2020
16 - Acquisition or disposition under a prospectus exemption
|
+$15,000 vol |
$15,000 | |
| Filed 2020-07-13 11:47 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Debentures (Non-Convertible) July 2020
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-13 11:28 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+25,500 vol |
386,015 | |
| Filed 2020-07-13 08:57 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$15,000 vol |
||
| Filed 2020-07-13 08:57 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$15,000 vol |
$15,000 | |
| Filed 2020-07-13 08:56 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-13 08:43 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+22,500 vol |
22,500 | |
| Filed 2020-07-13 08:41 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-10 11:15 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$-3,920
-3,500 vol $1.12 each |
5,000 | |
| Filed 2020-07-03 17:43 Tx date 2020-06-30 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+100,000 vol $0.60 each |
100,000 | |
| Filed 2020-07-03 17:42 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-02 15:22 Tx date 2020-06-30 |
$VPH
VALEO PHARMA INC. |
Saviuk, Helen
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2020-07-02 15:21 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Saviuk, Helen
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-02 15:04 Tx date 2020-06-30 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
465,810 | |
| Filed 2020-07-02 13:38 Tx date 2020-06-30 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+175,000 vol |
175,000 | |
| Filed 2020-07-02 13:37 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-02 13:34 Tx date 2020-06-30 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2020-07-02 13:33 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-02 09:21 Tx date 2020-06-30 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
322,222 | |
| Filed 2020-07-01 16:43 Tx date 2020-06-30 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+100,000 vol $0.60 each |
1,075,000 | |
| Filed 2020-05-25 12:10 Tx date 2020-05-25 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$32,000
+80,000 vol $0.40 each |
1,655,555 | |
| Filed 2020-05-19 16:41 Tx date 2020-05-14 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$2,250
+25,000 vol $0.09 each |
618,500 | |
| Filed 2020-05-19 13:19 Tx date 2020-05-14 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$3,400
+40,000 vol $0.085 each |
593,500 | |
| Filed 2020-02-28 18:07 Tx date 2020-02-27 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price)
16 - Acquisition or disposition under a prospectus exemption
|
$
+$154,000 vol $1,000 each |
$154,000 | |
| Filed 2020-02-28 18:06 Tx date 2019-09-24 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-28 18:00 Tx date 2020-02-27 |
$VPH
VALEO PHARMA INC. |
Hogue, Vincent
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price)
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100,000 vol $1,000 each |
$100,000 | |
| Filed 2020-02-28 18:00 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Hogue, Vincent
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-28 17:57 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures Series 1, 12%, 3 Years
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-28 17:54 Tx date 2020-02-27 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price)
16 - Acquisition or disposition under a prospectus exemption
|
$
+$1,040,000 vol $1,000 each |
$1,040,000 | |
| Filed 2020-02-28 17:53 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-28 17:33 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures Series 1, 12%, 3 Years
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-26 08:56 Tx date 2020-02-25 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$4,890
+10,000 vol $0.489 each |
1,068,000 | |
| Filed 2020-02-21 10:37 Tx date 2020-02-19 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$1,020
+2,000 vol $0.51 each |
2,303,636 | |
| Filed 2020-02-21 10:36 Tx date 2020-02-19 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$4,080
+8,000 vol $0.51 each |
2,301,636 | |
| Filed 2020-02-21 10:35 Tx date 2020-02-19 |
$VPH
VALEO PHARMA INC. |
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$4,800
+10,000 vol $0.48 each |
2,293,636 | |
| Filed 2020-02-19 15:02 Tx date 2020-02-19 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$7,440
+16,000 vol $0.465 each |
128,000 | |
| Filed 2020-02-19 15:01 Tx date 2020-02-18 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$5,580
+12,000 vol $0.465 each |
112,000 | |
| Filed 2020-02-18 11:11 Tx date 2020-02-18 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$910.00
+2,000 vol $0.455 each |
8,500 | |
| Filed 2020-02-12 10:50 Tx date 2020-02-12 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$30,443
+70,000 vol $0.4349 each |
1,058,000 | |
| Filed 2020-02-12 09:45 Tx date 2020-02-12 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$30,058
+70,000 vol $0.4294 each |
||
| Filed 2020-02-12 09:45 Tx date 2020-02-12 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$30,058
+70,000 vol $0.4294 each |
1,058,000 | |
| Filed 2020-01-02 16:40 Tx date 2019-12-31 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$8,988
+20,000 vol $0.4494 each |
988,000 | |
| Filed 2020-01-02 07:59 Tx date 2019-12-31 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$95.00
+1,000 vol $0.095 each |
553,500 | |
| Filed 2019-12-28 06:55 Tx date 2019-12-24 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$3,820
+8,000 vol $0.4775 each |
1,575,555 | |
| Filed 2019-12-26 07:47 Tx date 2019-12-23 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$4,250
+10,000 vol $0.425 each |
1,567,555 | |
| Filed 2019-12-20 12:26 Tx date 2019-12-19 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$1,975
+5,000 vol $0.395 each |
1,557,555 | |
| Filed 2019-12-17 12:51 Tx date 2019-12-17 |
$VPH
VALEO PHARMA INC. |
Skinner, Jeffrey Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$9,152
+26,000 vol $0.352 each |
968,000 | |
| Filed 2019-12-16 17:21 Tx date 2019-12-16 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$3,500
+10,000 vol $0.35 each |
1,552,555 | |
| Filed 2019-12-13 12:13 Tx date 2019-12-12 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$480.00
+1,500 vol $0.32 each |
1,542,555 | |
| Filed 2019-12-13 12:12 Tx date 2019-12-11 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$4,239
+15,000 vol $0.2826 each |
1,541,055 | |
| Filed 2019-12-09 16:50 Tx date 2019-09-24 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2019-12-09 16:49 Tx date 2019-09-24 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-09-26 16:27 Tx date 2019-09-24 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+200,000 vol |
||
| Filed 2019-12-05 17:10 Tx date 2019-12-05 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$2,925
+10,000 vol $0.2925 each |
1,526,055 | |
| Filed 2019-12-05 17:09 Tx date 2019-12-04 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$1,450
+5,000 vol $0.29 each |
1,516,055 | |
| Filed 2019-12-03 15:32 Tx date 2019-12-02 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$10,000
+200,000 vol $0.05 each |
452,500 | |
| Filed 2019-12-03 15:31 Tx date 2019-12-03 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$5,000
+100,000 vol $0.05 each |
552,500 | |
| Filed 2019-12-02 16:14 Tx date 2019-12-02 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$10,000
+200,000 vol $0.05 each |
||
| Filed 2019-12-02 16:14 Tx date 2019-12-02 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$10,000
+200,000 vol $0.05 each |
452,500 | |
| Filed 2019-12-02 14:17 Tx date 2019-11-28 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$17,750
+71,000 vol $0.25 each |
1,511,055 | |
| Filed 2019-10-23 11:01 Tx date 2019-10-22 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$25,000
+100,000 vol $0.25 each |
100,000 | |
| Filed 2019-10-23 08:26 Tx date 2019-10-22 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$20,000
+100,000 vol $0.20 each |
100,000 | |
| Filed 2019-10-23 08:26 Tx date 2019-10-22 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$20,000
+100,000 vol $0.20 each |
||
| Filed 2019-10-23 08:25 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-11 14:46 Tx date 2019-10-11 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$450.00
+1,500 vol $0.30 each |
6,500 | |
| Filed 2019-10-01 15:41 Tx date 2019-10-01 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$4,024
+11,500 vol $0.35 each |
1,440,055 | |
| Filed 2019-09-27 11:25 Tx date 2019-09-24 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2019-09-27 11:25 Tx date 2019-09-24 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2019-09-27 07:41 Tx date 2019-09-26 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$312.50
+1,000 vol $0.3125 each |
1,428,555 | |
| Filed 2019-09-26 16:23 Tx date 2019-09-25 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-09-26 16:18 Tx date 2019-09-25 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-09-26 16:27 Tx date 2019-09-24 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+200,000 vol |
400,000 | |
| Filed 2019-09-26 16:23 Tx date 2019-09-25 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2019-09-26 16:18 Tx date 2019-09-25 |
$VPH
VALEO PHARMA INC. |
Trudeau, Michel Claude
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2019-09-26 15:44 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: 9294-5351 Québec Inc. (Indirect Ownership)
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-09-25 08:51 Tx date 2019-09-19 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$2,800
+56,000 vol $0.05 each |
252,500 | |
| Filed 2019-09-20 08:00 Tx date 2019-09-19 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$70.00
+1,000 vol $0.07 each |
196,500 | |
| Filed 2019-09-18 13:38 Tx date 2019-09-18 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$46,398
+148,000 vol $0.3135 each |
1,427,555 | |
| Filed 2019-09-18 13:37 Tx date 2019-09-17 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$3,624
+12,500 vol $0.29 each |
1,279,555 | |
| Filed 2019-09-18 13:36 Tx date 2019-09-16 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$11,455
+39,500 vol $0.29 each |
1,267,055 | |
| Filed 2019-09-18 13:35 Tx date 2019-09-16 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$150.00
+1,500 vol $0.10 each |
195,500 | |
| Filed 2019-09-12 17:22 Tx date 2019-09-12 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$3,430
+49,000 vol $0.07 each |
194,000 | |
| Filed 2019-09-12 17:21 Tx date 2019-09-12 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,250
+25,000 vol $0.05 each |
145,000 | |
| Filed 2019-08-30 15:09 Tx date 2019-08-28 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Warrants
35 - Stock dividend
|
-1,253,327 vol |
360,515 | |
| Filed 2019-08-30 15:01 Tx date 2019-08-28 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Simcor Canada Holdings Inc. (Control or Direction)
|
Warrants
35 - Stock dividend
|
+601,354 vol |
601,354 | |
| Filed 2019-08-30 15:00 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Simcor Canada Holdings Inc. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-30 14:59 Tx date 2019-08-28 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
35 - Stock dividend
|
+104,300 vol |
104,300 | |
| Filed 2019-08-30 14:52 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-29 16:40 Tx date 2019-08-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$6,090
+21,000 vol $0.29 each |
1,227,555 | |
| Filed 2019-08-29 10:52 Tx date 2019-08-28 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
35 - Stock dividend
|
$6.50
+100 vol $0.065 each |
100 | |
| Filed 2019-08-29 10:42 Tx date 2019-08-28 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
35 - Stock dividend
|
+100 vol |
||
| Filed 2019-08-29 10:36 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-28 17:27 Tx date 2019-08-28 |
$VPH
VALEO PHARMA INC. |
Saviuk, Helen
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Klug Investments Inc (Control or Direction)
|
Warrants
35 - Stock dividend
|
$2,139
+32,909 vol $0.065 each |
32,909 | |
| Filed 2019-08-28 17:25 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Saviuk, Helen
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Klug Investments Inc (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-28 17:24 Tx date 2019-08-28 |
$VPH
VALEO PHARMA INC. |
Saviuk, Helen
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
35 - Stock dividend
|
$690.63
+10,625 vol $0.065 each |
58,428 | |
| Filed 2019-08-28 17:19 Tx date 2019-08-28 |
$VPH
VALEO PHARMA INC. |
Perry, Ronald S.
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants
35 - Stock dividend
|
$135.40
+2,083 vol $0.065 each |
2,083 | |
| Filed 2019-08-28 17:16 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Perry, Ronald S.
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-28 17:13 Tx date 2019-08-28 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
35 - Stock dividend
|
$-81,466.255
-1,253,327 vol $0.065 each |
360,515 | |
| Filed 2019-08-27 14:17 Tx date 2019-08-27 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$870.00
+3,000 vol $0.29 each |
380,969 | |
| Filed 2019-08-27 14:16 Tx date 2019-08-27 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$1,450
+5,000 vol $0.29 each |
377,969 | |
| Filed 2019-08-22 11:41 Tx date 2019-08-22 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$3,500
+10,000 vol $0.35 each |
1,206,555 | |
| Filed 2019-08-21 17:21 Tx date 2019-08-21 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$680.00
+2,000 vol $0.34 each |
1,196,555 | |
| Filed 2019-08-21 17:20 Tx date 2019-08-21 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$8,250
+25,000 vol $0.33 each |
1,194,555 | |
| Filed 2019-07-30 12:26 Tx date 2019-07-29 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$1,600
+4,000 vol $0.40 each |
372,969 | |
| Filed 2019-07-30 12:25 Tx date 2019-07-29 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$1,000
+2,500 vol $0.40 each |
368,969 | |
| Filed 2019-07-29 16:27 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,613,842 vol |
1,613,842 | |
| Filed 2019-07-29 16:26 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$806,921
+1,613,842 vol $0.50 each |
21,780,130 | |
| Filed 2019-07-29 13:53 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$25,000
+50,000 vol $0.50 each |
502,204 | |
| Filed 2019-07-29 13:52 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$25,000
+50,000 vol $0.50 each |
452,204 | |
| Filed 2019-07-29 13:51 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$25,000
+50,000 vol $0.50 each |
8,070,965 | |
| Filed 2019-07-29 13:51 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$25,000
+50,000 vol $0.50 each |
8,020,965 | |
| Filed 2019-07-29 13:43 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$25,000
+50,000 vol $0.50 each |
8,070,965 | |
| Filed 2019-07-29 13:43 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$25,000
+50,000 vol $0.50 each |
502,204 | |
| Filed 2019-07-29 13:42 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$25,000
+50,000 vol $0.50 each |
452,204 | |
| Filed 2019-07-29 13:41 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$25,000
+50,000 vol $0.50 each |
8,020,965 | |
| Filed 2019-07-29 08:06 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,613,842 vol |
1,613,842 | |
| Filed 2019-07-29 08:05 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$806,921
+1,613,842 vol $0.50 each |
21,780,130 | |
| Filed 2019-07-26 15:41 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,613,482 vol |
||
| Filed 2019-07-26 15:38 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$806,741
+1,613,482 vol $0.50 each |
||
| Filed 2019-07-26 12:14 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,613,482 vol |
||
| Filed 2019-07-26 12:10 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$806,741
+1,613,482 vol $0.50 each |
||
| Filed 2019-07-26 15:41 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,613,482 vol |
1,613,482 | |
| Filed 2019-07-26 15:39 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-26 15:38 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$806,741
+1,613,482 vol $0.50 each |
21,779,770 | |
| Filed 2019-07-26 14:44 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Simcor Canada Holdings Inc.
3 - 10% Security Holder of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,613,482 vol |
1,613,482 | |
| Filed 2019-07-26 14:42 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Simcor Canada Holdings Inc.
3 - 10% Security Holder of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-26 14:41 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Simcor Canada Holdings Inc.
3 - 10% Security Holder of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$806,741
+1,613,482 vol $0.50 each |
23,008,517 | |
| Filed 2019-07-26 12:21 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Saviuk, Helen
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+47,803 vol |
47,803 | |
| Filed 2019-07-26 12:20 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Saviuk, Helen
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-26 12:19 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Saviuk, Helen
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$23,901
+47,803 vol $0.50 each |
2,535,415 | |
| Filed 2019-07-26 12:14 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,613,482 vol |
1,613,482 | |
| Filed 2019-07-26 12:12 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-26 12:10 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Manitex Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$806,741
+1,613,482 vol $0.50 each |
21,779,770 | |
| Filed 2019-07-25 14:47 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$60,000
+120,000 vol $0.50 each |
120,000 | |
| Filed 2019-07-25 14:45 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-25 14:44 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$60,000
+120,000 vol $0.50 each |
1,169,555 | |
| Filed 2019-07-25 14:22 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$51,102
+102,204 vol $0.50 each |
402,204 | |
| Filed 2019-07-25 14:21 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$150,000
+300,000 vol $0.50 each |
300,000 | |
| Filed 2019-07-25 14:20 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-25 14:18 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$51,102
+102,204 vol $0.50 each |
7,970,965 | |
| Filed 2019-07-25 14:17 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$150,000
+300,000 vol $0.50 each |
7,868,761 | |
| Filed 2019-07-25 14:14 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$51,102
+102,204 vol $0.50 each |
402,204 | |
| Filed 2019-07-25 14:13 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$150,000
+300,000 vol $0.50 each |
300,000 | |
| Filed 2019-07-25 14:10 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-25 14:01 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$51,102
+102,204 vol $0.50 each |
7,970,965 | |
| Filed 2019-07-25 14:00 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$150,000
+300,000 vol $0.50 each |
7,868,761 | |
| Filed 2019-07-25 11:29 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$3,000
+7,500 vol $0.40 each |
1,049,555 | |
| Filed 2019-07-25 11:28 Tx date 2019-07-24 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$4,950
+11,000 vol $0.45 each |
1,042,055 | |
| Filed 2019-07-25 11:27 Tx date 2019-07-24 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$460.00
+1,000 vol $0.46 each |
1,031,055 | |
| Filed 2019-03-22 Tx date 2019-03-20 |
$VPH
VALEO PHARMA INC. |
MacKay, Richard J.
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: 100079 Canada Inc. (Indirect Ownership)
|
Common Shares Class A
36 - Conversion or exchange
|
$22,326
+55,815 vol $0.40 each |
7,568,761 | |
| Filed 2019-03-22 Tx date 2019-03-20 |
$VPH
VALEO PHARMA INC. |
100079 Canada Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares Class A
36 - Conversion or exchange
|
$22,326
+55,815 vol $0.40 each |
7,568,761 | |
| Filed 2019-03-22 Tx date 2019-03-20 |
$VPH
VALEO PHARMA INC. |
Hogue, Vincent
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
36 - Conversion or exchange
|
$962.40
+2,406 vol $0.40 each |
252,406 | |
| Filed 2019-03-20 Tx date 2019-03-20 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
36 - Conversion or exchange
|
$22.00
+55 vol $0.40 each |
1,030,055 | |
| Filed 2019-03-05 Tx date 2019-03-01 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$700.00
+1,000 vol $0.70 each |
1,030,000 |